413 related articles for article (PubMed ID: 11140637)
21. Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain.
Huang Y; Park YC; Rich RL; Segal D; Myszka DG; Wu H
Cell; 2001 Mar; 104(5):781-90. PubMed ID: 11257231
[TBL] [Abstract][Full Text] [Related]
22. Solid phase synthesis of Smac/DIABLO-derived peptides using a 'Safety-Catch' resin: identification of potent XIAP BIR3 antagonists.
Elsawy MA; Martin L; Tikhonova IG; Walker B
Bioorg Med Chem; 2013 Sep; 21(17):5004-11. PubMed ID: 23886811
[TBL] [Abstract][Full Text] [Related]
23. Identification of mammalian mitochondrial proteins that interact with IAPs via N-terminal IAP binding motifs.
Verhagen AM; Kratina TK; Hawkins CJ; Silke J; Ekert PG; Vaux DL
Cell Death Differ; 2007 Feb; 14(2):348-57. PubMed ID: 16794601
[TBL] [Abstract][Full Text] [Related]
24. Biochemical basis for enhanced binding of peptide dimers to X-linked inhibitor of apoptosis protein.
Splan KE; Allen JE; McLendon GL
Biochemistry; 2007 Oct; 46(42):11938-44. PubMed ID: 17910418
[TBL] [Abstract][Full Text] [Related]
25. Interaction between XIAP and Smac/DIABLO in the mouse brain after transient focal cerebral ischemia.
Saito A; Hayashi T; Okuno S; Ferrand-Drake M; Chan PH
J Cereb Blood Flow Metab; 2003 Sep; 23(9):1010-9. PubMed ID: 12973017
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria.
Zhang XD; Zhang XY; Gray CP; Nguyen T; Hersey P
Cancer Res; 2001 Oct; 61(19):7339-48. PubMed ID: 11585775
[TBL] [Abstract][Full Text] [Related]
27. Structure-based design, synthesis and biochemical testing of novel and potent Smac peptido-mimetics.
Sun H; Nikolovska-Coleska Z; Chen J; Yang CY; Tomita Y; Pan H; Yoshioka Y; Krajewski K; Roller PP; Wang S
Bioorg Med Chem Lett; 2005 Feb; 15(3):793-7. PubMed ID: 15664859
[TBL] [Abstract][Full Text] [Related]
28. Structural biology. Controlling the caspases.
Fesik SW; Shi Y
Science; 2001 Nov; 294(5546):1477-8. PubMed ID: 11711663
[No Abstract] [Full Text] [Related]
29. Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization.
Nikolovska-Coleska Z; Wang R; Fang X; Pan H; Tomita Y; Li P; Roller PP; Krajewski K; Saito NG; Stuckey JA; Wang S
Anal Biochem; 2004 Sep; 332(2):261-73. PubMed ID: 15325294
[TBL] [Abstract][Full Text] [Related]
30. Smac3, a novel Smac/DIABLO splicing variant, attenuates the stability and apoptosis-inhibiting activity of X-linked inhibitor of apoptosis protein.
Fu J; Jin Y; Arend LJ
J Biol Chem; 2003 Dec; 278(52):52660-72. PubMed ID: 14523016
[TBL] [Abstract][Full Text] [Related]
31. Opposite regulation of XIAP and Smac/DIABLO in the rat endometrium in response to 17beta-estradiol at estrus.
Leblanc V; Dery MC; Shooner C; Asselin E
Reprod Biol Endocrinol; 2003 Aug; 1():59. PubMed ID: 12967350
[TBL] [Abstract][Full Text] [Related]
32. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.
Roa WH; Chen H; Fulton D; Gulavita S; Shaw A; Th'ng J; Farr-Jones M; Moore R; Petruk K
Clin Invest Med; 2003 Oct; 26(5):231-42. PubMed ID: 14596484
[TBL] [Abstract][Full Text] [Related]
33. Neuronal apoptosis inhibitory protein, NAIP, is an inhibitor of procaspase-9.
Davoodi J; Ghahremani MH; Es-Haghi A; Mohammad-Gholi A; Mackenzie A
Int J Biochem Cell Biol; 2010 Jun; 42(6):958-64. PubMed ID: 20171302
[TBL] [Abstract][Full Text] [Related]
34. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
Wu SJ; Ng LT; Lin CC
Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126
[TBL] [Abstract][Full Text] [Related]
35. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
Yang L; Mashima T; Sato S; Mochizuki M; Sakamoto H; Yamori T; Oh-Hara T; Tsuruo T
Cancer Res; 2003 Feb; 63(4):831-7. PubMed ID: 12591734
[TBL] [Abstract][Full Text] [Related]
36. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation.
Checinska A; Hoogeland BS; Rodriguez JA; Giaccone G; Kruyt FA
Exp Cell Res; 2007 Apr; 313(6):1215-24. PubMed ID: 17291493
[TBL] [Abstract][Full Text] [Related]
37. Substrate cleavage by caspases generates protein fragments with Smac/Diablo-like activities.
Hell K; Saleh M; Crescenzo GD; O'Connor-McCourt MD; Nicholson DW
Cell Death Differ; 2003 Nov; 10(11):1234-9. PubMed ID: 14576775
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a heterodimeric Smac-based peptide that features sequences specific to both the BIR2 and BIR3 domains of the X-linked inhibitor of apoptosis protein.
Speer KF; Cosimini CL; Splan KE
Biopolymers; 2012; 98(2):122-30. PubMed ID: 22020922
[TBL] [Abstract][Full Text] [Related]
39. Endogenously released Smac is insufficient to mediate cell death of human lung carcinoma in response to etoposide.
Bartling B; Lewensohn R; Zhivotovsky B
Exp Cell Res; 2004 Aug; 298(1):83-95. PubMed ID: 15242764
[TBL] [Abstract][Full Text] [Related]
40. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway.
Srinivasula SM; Datta P; Fan XJ; Fernandes-Alnemri T; Huang Z; Alnemri ES
J Biol Chem; 2000 Nov; 275(46):36152-7. PubMed ID: 10950947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
